Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

6.59

Margin Of Safety %

-23

Put/Call OI Ratio

0.53

EPS Next Q Diff

0.11

EPS Last/This Y

1.52

EPS This/Next Y

0.05

Price

15.09

Target Price

20.13

Analyst Recom

2.3

Performance Q

-4.19

Relative Volume

0.69

Beta

1.84

Ticker: TXG



20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19TXG13.610.391.507875
2024-12-20TXG14.060.361.047722
2024-12-23TXG14.790.440.034704
2024-12-24TXG14.670.413.364902
2024-12-26TXG14.680.450.165067
2024-12-27TXG14.610.450.585125
2024-12-30TXG14.350.440.335215
2024-12-31TXG14.370.440.175251
2025-01-02TXG14.180.440.055292
2025-01-03TXG15.610.440.925312
2025-01-06TXG15.930.440.355388
2025-01-07TXG15.520.430.815907
2025-01-08TXG15.830.450.896064
2025-01-09TXG15.830.450.856064
2025-01-10TXG15.580.441.056082
2025-01-13TXG15.720.500.336856
2025-01-14TXG15.430.511.096898
2025-01-15TXG15.050.520.727000
2025-01-16TXG15.090.530.687156
2025-01-17TXG15.090.530.357202
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19TXG13.61-286.3-12.9-0.66
2024-12-20TXG14.06-286.3-17.2-0.66
2024-12-23TXG14.73-286.3-20.8-0.66
2024-12-24TXG14.67-286.3-8.8-0.66
2024-12-26TXG14.67-286.3-9.8-0.66
2024-12-27TXG14.60-286.3-8.6-0.66
2024-12-30TXG14.35-286.3-6.0-0.66
2024-12-31TXG14.36-286.3-9.9-0.66
2025-01-02TXG14.19-286.3-6.9-0.66
2025-01-03TXG15.61-286.3-32.3-0.66
2025-01-06TXG15.94-286.3-14.5-0.66
2025-01-07TXG15.52-286.3-4.2-0.66
2025-01-08TXG15.83-286.3-13.9-0.66
2025-01-09TXG15.83-286.3-9.7-0.66
2025-01-10TXG15.58-286.3-6.2-0.66
2025-01-13TXG15.70-286.3-11.5-0.66
2025-01-14TXG15.42-286.3-9.2-0.66
2025-01-15TXG14.98-286.3-6.9-0.66
2025-01-16TXG15.07-286.3-15.0-0.66
2025-01-17TXG15.09-286.3-14.2-0.66
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19TXG-0.12-0.956.92
2024-12-20TXG-0.12-0.956.92
2024-12-23TXG-0.12-0.956.92
2024-12-24TXG-0.12-0.956.92
2024-12-26TXG-0.13-0.956.19
2024-12-27TXG-0.12-0.956.19
2024-12-30TXG-0.13-0.916.19
2024-12-31TXG-0.13-0.916.19
2025-01-02TXG-0.12-0.916.19
2025-01-03TXG-0.12-0.916.19
2025-01-06TXG-0.11-0.846.19
2025-01-07TXG-0.11-0.846.19
2025-01-08TXG-0.12-0.846.19
2025-01-09TXG-0.12-0.846.19
2025-01-10TXG-0.12-0.846.19
2025-01-13TXG-0.12-0.856.59
2025-01-14TXG-0.13-0.856.59
2025-01-15TXG-0.13-0.856.59
2025-01-16TXG-0.13-0.856.59
2025-01-17TXG-0.13-0.856.59
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

-0.3

Avg. EPS Est. Current Quarter

-0.15

Avg. EPS Est. Next Quarter

-0.19

Insider Transactions

-0.13

Institutional Transactions

-0.85

Beta

1.84

Average Sales Estimate Current Quarter

153

Average Sales Estimate Next Quarter

142

Fair Value

11.63

Quality Score

44

Growth Score

50

Sentiment Score

25

Actual DrawDown %

92.8

Max Drawdown 5-Year %

-93.5

Target Price

20.13

P/E

Forward P/E

PEG

P/S

2.9

P/B

2.53

P/Free Cash Flow

70.1

EPS

-1.53

Average EPS Est. Cur. Y​

-0.66

EPS Next Y. (Est.)

-0.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-28.99

Relative Volume

0.69

Return on Equity vs Sector %

-44.3

Return on Equity vs Industry %

-38.6

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.01

EBIT Estimation

-14.2
10x Genomics, Inc.
Sector: Healthcare
Industry: Health Information Services
Employees: 1259
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today
news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance
stock history TXG – 10x Genomics, Inc. invest stock market
stock prices TXG premarket after hours
ticker TXG fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Facebook-f Twitter Tiktok Instagram Youtube

Get Started

About